Abnil (120Mg) 30 Capsules
Orlistat-based weight management capsules that reduce dietary fat absorption for obesity treatment.
Abnil capsules contain Orlistat, a reversible inhibitor of gastrointestinal lipase enzymes that prevents dietary fat absorption. It works by forming a covalent bond with gastric and pancreatic lipase, preventing the breakdown of triglycerides into absorbable free fatty acids and monoglycerides. This creates a caloric deficit that supports weight loss in obese patients when combined with a reduced-calorie diet.
Purpose
Treatment and management of obesity, including weight loss and weight maintenance when combined with a reduced-calorie diet.
Ingredients
Orlistat 120mg
Warnings
Not recommended for patients with chronic malabsorption syndrome or cholestasis. May reduce absorption of fat-soluble vitamins. Consult doctor if you have kidney stones, pancreatitis, or liver disease. BMI criteria apply: ≥30 kg/m² or ≥27 kg/m² with risk factors.
Side Effects
Oily spotting, flatulence with discharge, fecal urgency, fatty or oily stools, increased defecation, oily evacuation, abdominal pain.
Storage Instructions
Store at room temperature away from moisture and heat. Keep out of reach of children.
| Brand | AGP Pharma |
| Status | Active |
Related Products
